Invention Grant
- Patent Title: Antibody specific for CD22 and methods of use thereof
-
Application No.: US17408113Application Date: 2021-08-20
-
Publication No.: US12116409B2Publication Date: 2024-10-15
- Inventor: David Rabuka , Robert George Edward Holgate , Francis Joseph Carr
- Applicant: Redwood Bioscience, Inc.
- Applicant Address: US CA Emeryville
- Assignee: Redwood Bioscience, Inc.
- Current Assignee: Redwood Bioscience, Inc.
- Current Assignee Address: US CA Emeryville
- Agency: Bozicevic, Field & Francis LLP
- Agent Rudy J. Ng; Mandar Joshi
- Main IPC: C07K16/00
- IPC: C07K16/00 ; A61K39/395 ; A61K39/40 ; C07K16/28 ; C07K17/02 ; C07K17/08 ; C07K17/10 ; C12N9/16 ; C12P21/08
Abstract:
The present disclosure provides antibodies specific for an epitope present on CD22. The antibodies are useful in various treatment, diagnostic, and monitoring applications, which are also provided.
Public/Granted literature
- US20220220198A1 ANTIBODY SPECIFIC FOR CD22 AND METHODS OF USE THEREOF Public/Granted day:2022-07-14
Information query
